This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. advanced 4.7% to $959.41 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.3% to 7,619.38 and the Dow Jones Industrial Average rising 0.5% to 52,486.49.
Regeneron Pharmaceuticals Inc. closed 3.3% below its 52-week high of $991.73, which the company reached on November 4th.
The stock outperformed some of its peers, as Amgen Inc. rose 0.6% to $468.11, Moderna Inc. fell 0.9% to $248.69, and Gilead Sciences Inc. fell 0.67% to $169.73.
Trading volume totaled 1.2 million, compared to the 50-day average of 801,966.
Data source: Dow Jones Market Data, FactSet
Comments